Neurobiology of Aging
Volume 27, Issue 10 , Pages 1440-1444 , October 2006

Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease

  • Ayla Ozturk

      Affiliations

    • Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, 624 Parran Hall, Pittsburgh, PA 15261, USA
    • ,
  • Steven T. DeKosky

      Affiliations

    • Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, 624 Parran Hall, Pittsburgh, PA 15261, USA
    • Alzheimer's Disease Research Center, School of Medicine, University of Pittsburgh, PA 15213, USA
    • Department of Neurology, School of Medicine, University of Pittsburgh, PA 15213, USA
    • ,
  • M. Ilyas Kamboh

      Affiliations

    • Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, 624 Parran Hall, Pittsburgh, PA 15261, USA
    • Alzheimer's Disease Research Center, School of Medicine, University of Pittsburgh, PA 15213, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 412 624 3066; fax: +1 412 383 7844.

Received 17 May 2005 ,Revised 27 July 2005 ,Accepted 20 August 2005.

References 

  1. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982;217:408–414
  2. Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 2000;290:2302–2303
  3. Cook LJ, Ho LW, Wang L, Terrenoire E, Brayne C, Evans JG, et al. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet (B Neuropsychiatr Genet). 2005;132:5–8
  4. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, et al. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science. 2000;290:2303–2304
  5. Harold D, Peirce T, Moskvina V, Myers A, Jones S, Hollingworth P, et al. Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum Genet. 2003;113:258–267
  6. Ihaka G. A language for data analysis and graphics. J Comp Graphic Stat. 1996;5:299–314
  7. Kamboh MI. Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet. 2004;68:381–404
  8. Kim KW, Suh YJ, Park WY, Jhoo JH, Lee DY, Youn JC, et al. Choline acetyltransferase G+4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4. Neurosci Lett. 2004;366:182–186
  9. Lewontin R. The interaction of selection and linkage I: general considerations, hetorotic models. Genetics. 1964;49:49–67
  10. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, et al. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet. 2002;70:985–993
  11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  12. Mubumbila V, Sutter A, Ptok U, Heun R, Quirin-Stricker C. Identification of a single nucleotide polymorphism in the choline acetyltransferase gene associated with Alzheimer's disease. Neurosci Lett. 2002;333:9–12
  13. Myers A, Wavrant De-Vrieze F, Holmans P, Holmans P, Hamshere M, Crook R, et al. Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet. 2002;114:235–244
  14. Oda Y. Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol Int. 1999;49:921–937
  15. Schwarz S, Eisele T, Diehl J, Muller U, Forstl H, Kurz A, et al. Lack of association between a single nucleotide polymorphism within the choline acetyltransferase gene and patients with Alzheimer's disease. Neurosci Lett. 2003;343:167–170
  16. Seshadri S, Drachman DA, Lippa CF. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Arch Neurol. 1995;52:1074–1079
  17. Slooter AJ, Cruts M, Kalmijn S, Kalmijn S, Hoffman A, Breteler MM, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol. 1998;55:964–968
  18. Wang X, DeKosky ST, Luedecking-Zimmer E, Ganguli M, Kamboh IM. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease. Hum Genet. 2002;110:356–365
  19. Wilcock GK, Esiri MM, Bowen DM, Smith CC. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci. 1982;57:407–417

PII: S0197-4580(05)00228-9

doi: 10.1016/j.neurobiolaging.2005.08.024

Neurobiology of Aging
Volume 27, Issue 10 , Pages 1440-1444 , October 2006

Article Tools